I
Injective
Develops a fully-decentralized exchange protocol that eliminates front-running and allows for trustless liquidity sharing
Latest news
Press, funding announcements and product moves mentioning Injective.
Investors
From Dealroom's funding and investor records, grouped by the round each investor first entered.
Seed7 investors entered at this stage
- BVBoxOne Ventures
- ICInnovating Capital
- KGKrypital Group
- BIBitScale
- TCThe Cabin Capital
Pantera Capital- QSQCP Soteria
Series B and later1 investor entered at this stage
- JCJump Crypto
Ownership
Estimated cap table from Dealroom's shareholder data — share of equity by holder. Stakes as last recorded by Dealroom (2026). Percentages are indicative.
Some investors are hidden on this public profile. See the full cap table on Dealroom →
Source: Dealroom Talent Intelligence.
Global footprint
team presence
across markets
Investments and acquisitions
Disclosed deals where Injective was the backer or acquirer, 2021–2021. Toggle between venture rounds, M&A, or both. The map below is grouped by the target company's sector — the colored pill on each chip is the round type.
3 deals across Injective's capital deployment.
Where the deals concentrate by sector, stage, and decade.
Injective's portfolio, mapped.
Each chip is one company. Pill colour shows round type — green for Seed, blue for Series A, purple for B/C+, pink for late-stage, amber for M&A. Bigger sectors keep their full list behind “+ N more”.
Market sentiment
An AI-synthesised read of the highest-engagement posts about Injective on X, ranked by likes and reposts, corporate channels excluded.
Reading the room on X — pulling top posts and synthesizing themes…
Source: X recent search ranked by engagement (likes + retweets) · Synthesis by Claude · Cached for 1 hour
See Injective on the full Dealroom platform
Live deal flow, founder pedigree, hiring signals, revenue trajectory, and the full cap table.